Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CJD and the dentist.

Andrew Smith1, Jeremy Bagg

  • 1Infection Research Group, Glasgow Dental Hospital and School, 378 Sauchiehall Street, Glasgow.

Dental Update
|July 2, 2003
PubMed
Summary
This summary is machine-generated.

Variant Creutzfeldt-Jakob disease (vCJD) is a new prion disease. Abnormal prion proteins cause vCJD, posing challenges for sterilization and patient management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scientific Opinion of Flavouring Group Evaluation 407 (FGE.407): 4-amino-5-(3-(isopropylamino)-2,2-dimethyl-3-oxopropoxy)-2-methylquinoline-3-carboxylic acid.

EFSA journal. European Food Safety Authority·2020
Same author

Safety assessment of the substance 'Tungsten Oxide' for use in food contact materials.

EFSA journal. European Food Safety Authority·2020
Same author

Scientific Opinion on Flavouring Group Evaluation 63, Revision 3 (FGE.63Rev3): aliphatic secondary alcohols, ketones and related esters evaluated by JECFA (59th and 69th meetings) structurally related to saturated and unsaturated aliphatic secondary alcohols, ketones and esters of secondary alcohols and saturated linear or branched-chain carboxylic acids evaluated by EFSA in FGE.07Rev4.

EFSA journal. European Food Safety Authority·2020
Same author

Safety evaluation of the food enzyme pullulanase from <i>Pullulanibacillus naganoensis</i> strain AE-PL.

EFSA journal. European Food Safety Authority·2020
Same author

Safety evaluation of the food enzyme peroxidase obtained from soybean (<i>Glycine max</i>) hulls.

EFSA journal. European Food Safety Authority·2020
Same author

Safety assessment of the mixture of methyl-branched and linear C<sub>14</sub>-C<sub>18</sub> alkanamides, derived from fatty acids, for use in food contact materials.

EFSA journal. European Food Safety Authority·2020
Same journal

Technique Tips – Iatrogenesis and How to Prevent It.

Dental update·2017
Same journal

Clinical Challenges Q&A 31. Painful Lip.

Dental update·2017
Same journal

Dual Role of Subepithelial Connective Tissue Grafting in Regeneration of Periodontal Attachment Apparatus.

Dental update·2017
Same journal

Ceramic Fracture in Metal-Ceramic Restorations: The Aetiology.

Dental update·2017
Same journal

Arteriovenous Malformation of the Jaws: a Black Hole for the GDP – A Case Report.

Dental update·2017
Same journal

The Immune System: Basis of so much Health and Disease: 4. Immunocytes.

Dental update·2017
See all related articles

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pathology

Background:

  • Variant Creutzfeldt-Jakob disease (vCJD) is a recently emerged human prion disease.
  • Prion diseases are characterized by abnormal prion proteins, which are infectious agents.
  • These agents are notably resistant to standard sterilization methods.

Purpose of the Study:

  • To review the clinical manifestations of human prion diseases.
  • To provide background on the biological nature of prions.
  • To discuss challenges in infection control and patient management guidelines for transmissible spongiform encephalopathies.

Main Methods:

  • Literature review of clinical manifestations of human prion diseases.
  • Review of the biological characteristics of prion proteins.

Related Experiment Videos

  • Analysis of infection control challenges and current patient management guidelines.

    • Main Results:

    • Human prion diseases, including vCJD, present diverse clinical symptoms.
    • Prion proteins exhibit unique biological properties and resistance to conventional sterilization.
    • Effective infection control and patient management require specific protocols.

    Conclusions:

    • Understanding prion disease pathology is crucial for diagnosis and management.
    • The resistance of prions to sterilization necessitates specialized infection control measures.
    • Updated guidelines are essential for the safe management of patients with transmissible spongiform encephalopathies.